Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 121-130 of 1154 total displayed.

Past content (since Jan 1999):

Articles
Efficacy of In-Hospital Multidimensional Interventions of Secondary Prevention After Acute Coronary Syndrome. A Systematic Review and Meta-Analysis
Reto Auer, Jacques Gaume, Nicolas Rodondi, Jacques Cornuz, and William A. Ghali
Circulation published June 9, 2008, doi:10.1161/CIRCULATIONAHA.107.748095 [Abstract]  

Editorials
Aspirin Chemoprevention: One Size Does Not Fit All
Lori Mosca
Circulation 2008;117:2844-2846, doi:10.1161/CIRCULATIONAHA.108.778407 [Full text]  

Special Report
Acute Pharmacological Conversion of Atrial Fibrillation to Sinus Rhythm: Is Short-Term Symptomatic Therapy Worth It? A Report From the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration
William R. Hiatt, A. Michael Lincoff, and Robert A. Harrington
Circulation 2008;117:2956-2957, doi:10.1161/CIRCULATIONAHA.108.780155 [Full text]  

Articles
Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction
Felix M. Gonzalez, Sruti Shiva, Pamela S. Vincent, Lorna A. Ringwood, Li-Yueh Hsu, Yuen Yi Hon, Anthony H. Aletras, Richard O. Cannon, III, Mark T. Gladwin, and Andrew E. Arai
Circulation published June 2, 2008, doi:10.1161/CIRCULATIONAHA.107.748814 [Abstract]  

Articles
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension. Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz, Fernando Torres, Adaani Frost, Hossein A. Ghofrani, David B. Badesch, Michael D. McGoon, Vallerie V. McLaughlin, Ellen B. Roecker, Michael J. Gerber, Christopher Dufton, Brian L. Wiens, Lewis J. Rubin for the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group
Circulation published May 27, 2008, doi:10.1161/CIRCULATIONAHA.107.742510 [Abstract]  

Molecular Cardiology
Inhibition of GSK3β by Postconditioning Is Required to Prevent Opening of the Mitochondrial Permeability Transition Pore During Reperfusion
Ludovic Gomez, Mélanie Paillard, Hélène Thibault, Geneviève Derumeaux, and Michel Ovize
Circulation 2008;117:2761-2768; published online before print as doi:10.1161/CIRCULATIONAHA.107.755066 [Abstract] [Full text]  

Heart Failure
Reversal of Cardiac Hypertrophy and Fibrosis From Pressure Overload by Tetrahydrobiopterin: Efficacy of Recoupling Nitric Oxide Synthase as a Therapeutic Strategy
An L. Moens, Eiki Takimoto, Carlo G. Tocchetti, Khalid Chakir, Djahida Bedja, Gianfranco Cormaci, Elizabeth A. Ketner, Maulik Majmudar, Kathleen Gabrielson, Marc K. Halushka, James B. Mitchell, Shyam Biswal, Keith M. Channon, Michael S. Wolin, Nicholas J. Alp, Nazareno Paolocci, Hunter C. Champion, and David A. Kass
Circulation 2008;117:2626-2636; published online before print as doi:10.1161/CIRCULATIONAHA.107.737031 [Abstract] [Full text]  

Vascular Medicine
Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
Antonio Abbate, Fadi N. Salloum, Elena Vecile, Anindita Das, Nicholas N. Hoke, Stefania Straino, Giuseppe G.L. Biondi-Zoccai, Jon-Erik Houser, Ian Z. Qureshi, Evan D. Ownby, Edoardo Gustini, Luigi M. Biasucci, Anna Severino, Maurizio C. Capogrossi, George W. Vetrovec, Filippo Crea, Alfonso Baldi, Rakesh C. Kukreja, and Aldo Dobrina
Circulation 2008;117:2670-2683; published online before print as doi:10.1161/CIRCULATIONAHA.107.740233 [Abstract] [Full text]  

Controversies in Cardiovascular Medicine
Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension
Franz H. Messerli, Sripal Bangalore, and Stevo Julius
Circulation 2008;117:2706-2715, doi:10.1161/CIRCULATIONAHA.107.695007 [Full text]  

Articles
Inhibition of GSK3{beta} by Postconditioning Is Required to Prevent Opening of the Mitochondrial Permeability Transition Pore During Reperfusion
Ludovic Gomez, Mélanie Paillard, Hélène Thibault, Geneviève Derumeaux, and Michel Ovize
Circulation published May 19, 2008, doi:10.1161/CIRCULATIONAHA.107.755066 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment